{"id":"https://openalex.org/W2181980570","doi":null,"title":"Statin Therapy on Insulin Resistance and Plasma Level of Adiponectin in Non-Diabetic, Hypercholesterolemic Patients","display_name":"Statin Therapy on Insulin Resistance and Plasma Level of Adiponectin in Non-Diabetic, Hypercholesterolemic Patients","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2181980570","mag":"2181980570"},"language":"en","primary_location":{"id":"mag:2181980570","doi":null,"is_oa":false,"landing_page_url":"http://www.tsoc.org.tw/upload/journal/1/20091231/2.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113685581","display_name":"Philip Yu\u2010An Ding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Philip Yu\u2010An Ding","raw_affiliation_strings":["Taipei Veterans General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taipei Veterans General Hospital","institution_ids":["https://openalex.org/I2803004286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039777024","display_name":"Pai\u2010Feng Hsu","orcid":"https://orcid.org/0000-0003-3234-7941","observed_orcids":["https://orcid.org/0000-0003-3234-7941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pai\u2010Feng Hsu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3234-7941","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5039127589","display_name":"Tse\u2010Min Lu","orcid":"https://orcid.org/0000-0002-9730-8356","observed_orcids":["https://orcid.org/0000-0002-9730-8356"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tse\u2010Min Lu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9730-8356","affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6345,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.72599362,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.7139000296592712,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.7139000296592712,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.26420000195503235,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9100000262260437},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.875},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9559999704360962},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.8040000200271606},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9470000267028809},{"id":"https://openalex.org/keywords/non-diabetic-patients","display_name":"non-diabetic patients","score":0.8560000061988831},{"id":"https://openalex.org/keywords/homa-index","display_name":"HOMA index","score":0.9210000038146973},{"id":"https://openalex.org/keywords/plasma-glucose","display_name":"plasma glucose","score":0.5360000133514404},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.9128027558326721},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8258870840072632},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7624459862709045},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.7509328722953796},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6683295965194702},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.6294405460357666},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5519494414329529},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5215473175048828},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48660528659820557},{"id":"https://openalex.org/C3017594256","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin sensitivity","level":4,"score":0.4829689562320709}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2181980570","doi":null,"is_oa":false,"landing_page_url":"http://www.tsoc.org.tw/upload/journal/1/20091231/2.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1967174170","https://openalex.org/W1980261014","https://openalex.org/W1981261500","https://openalex.org/W1984230001","https://openalex.org/W1986949841","https://openalex.org/W2003382978","https://openalex.org/W2006835279","https://openalex.org/W2009576508","https://openalex.org/W2018337014","https://openalex.org/W2030335991","https://openalex.org/W2038393880","https://openalex.org/W2042082439","https://openalex.org/W2048034841","https://openalex.org/W2049965571","https://openalex.org/W2059582640","https://openalex.org/W2061489988","https://openalex.org/W2075345318","https://openalex.org/W2076706839","https://openalex.org/W2085910655","https://openalex.org/W2095238078","https://openalex.org/W2095726149","https://openalex.org/W2096478205","https://openalex.org/W2104041304","https://openalex.org/W2108931588","https://openalex.org/W2111421981","https://openalex.org/W2113670840","https://openalex.org/W2115950200","https://openalex.org/W2120192015","https://openalex.org/W2127934772","https://openalex.org/W2130760108","https://openalex.org/W2135298791","https://openalex.org/W2138750223","https://openalex.org/W2139801418","https://openalex.org/W2155598961","https://openalex.org/W2160234571","https://openalex.org/W2163572786","https://openalex.org/W2165663485","https://openalex.org/W2166370133","https://openalex.org/W2322095705","https://openalex.org/W2607412715","https://openalex.org/W4246764494"],"related_works":["https://openalex.org/W2071632412","https://openalex.org/W1967174170","https://openalex.org/W2164781406","https://openalex.org/W7217816363","https://openalex.org/W2798157513","https://openalex.org/W2097264002","https://openalex.org/W2030335991","https://openalex.org/W2000380429","https://openalex.org/W2461236753","https://openalex.org/W2165663485"],"abstract_inverted_index":{"Background:":[0],"Adiponectin":[1],"is":[2],"an":[3],"adipocyte-derived":[4],"plasma":[5,20,76,129,153,191,216],"protein":[6],"with":[7,122,148,205],"various":[8],"anti-atherogenic":[9],"properties.":[10],"However,":[11,145],"the":[12,127,137,146,152,173,186,190,215],"effect":[13],"of":[14,22,78,131,140,155,166,181,193,218],"statins":[15,141,206],"on":[16,142],"insulin":[17,133,143,187,213],"sensitivity":[18,71,188],"and":[19,33,60,75,83,102,117,189,199],"level":[21,77,104,130,154,192,217],"adiponectin":[23,79,103,156,194,219],"remains":[24],"controversial.":[25],"Methods:":[26],"Forty-eight":[27],"non-diabetic,":[28,62],"hypercholesterolemic":[29,116,198],"patients":[30,64],"were":[31,65,80,113,195],"enrolled":[32,66],"assigned":[34],"to":[35,160],"statin":[36,49,123,149,175],"treatment":[37,50,87,121,147,176,204],"(atorvastatin":[38],"10":[39],"or":[40,47,134],"40":[41],"mg)":[42],"group":[43,51],"(n":[44,52],"=":[45,53,100,111],"27)":[46],"no":[48,174],"21).":[54],"In":[55],"addition,":[56],"another":[57],"20":[58],"age-":[59],"sex-matched":[61],"normocholesterolemic":[63,118,200],"as":[67],"control":[68],"group.":[69,177],"Insulin":[70],"(indicated":[72],"by":[73],"HOMAindex)":[74],"determined":[81],"before":[82],"6":[84,208],"weeks":[85,209],"after":[86],"in":[88,172],"all":[89],"patients.":[90,119,202],"Results:":[91],"The":[92,120,179],"HOMAindex":[93],"(1.76":[94],"0.81":[95],"vs.":[96,107],"1.42":[97],"0.57,":[98],"p":[99,110],"0.09)":[101],"(8.22":[105],"2.83g/dl":[106],"9.23":[108],"4.36g/dl,":[109],"0.26)":[112],"similar":[114,196],"between":[115,197],"did":[124,169,210],"not":[125,170,211],"affect":[126],"fasting":[128],"glucose,":[132],"HOMAindex,":[135],"suggesting":[136],"neutral":[138],"effects":[139],"sensitivity.":[144],"significantly":[150,220],"reduced":[151],"(from":[157],"8.6":[158],"3.1g/ml":[159],"7.8":[161],"3.2g/ml,":[162],"P=":[163],"0.01).":[164],"All":[165],"these":[167],"variables":[168],"change":[171],"Conclusion:":[178],"result":[180],"this":[182],"study":[183],"showed":[184],"that":[185],"non-diabetic":[201],"Although":[203],"for":[207],"deteriorate":[212],"sensitivities,":[214],"decreased.":[221]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}